Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluating Radioactive Analogs of Doxorubicin to Quantify ChemoFilter Binding and Whole-Body Positron Emission Tomography/Magnetic Resonance Imaging for Drug Biodistribution

Journal of Vascular and Interventional Radiology(2022)10.1016/j.jvir.2022.03.007Source: DataRank Database

Evaluating Radioactive Analogs of Doxorubicin to Quantify ChemoFilter Binding and Whole-Body Positron Emission Tomography/Magnetic Resonance Imaging for Drug Biodistribution is a research paper published in Journal of Vascular and Interventional Radiology (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.13)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Colin Yee,Joseph Blecha,Thomas R. Hayes,B Kilbride ORCID,Carol Stillson ORCID

Live enrichment

PubMed:35301127 PMC:PMC9156544 OpenAlex:https://openalex.org/W4220851393

National Institutes of Health

Grant: R01 CA194533

NIGMS NIH HHS

Grant: T32 GM145449

NIBIB NIH HHS

Grant: R01 EB012031

NCI NIH HHS

Grant: R42 CA265316

National Institutes of Health

Grant: 5R01CA194533-02

Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity

Siemens

FWCI

0.13

Citation Percentile

0.4%

Citation Trend

2023

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9156544

publisherhttps://api.elsevier.com/content/article/PII:S1051044322001208?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1051044322001208?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jvir.2022.03.007

Fields of Study

Hepatocellular Carcinoma Treatment and PrognosisChemotherapy-induced cardiotoxicity and mitigationRadiopharmaceutical Chemistry and ApplicationsAnimalsDoxorubicinHepatic ArteryHumansMagnetic Resonance ImagingPositron-Emission TomographySwineTissue Distribution

MeSH Terms

AnimalsDoxorubicinHepatic ArteryHumansMagnetic Resonance ImagingSwineTissue DistributionPositron-Emission Tomography

Keywords

BiodistributionMedicinePositron emission tomographyMagnetic resonance imagingNuclear medicinePositron emissionPreclinical imagingNuclear magnetic resonanceMedical physicsRadiologyIn vivoPhysicsBiomedical and Clinical SciencesSwineClinical SciencesBioengineeringNuclear Medicine & Medical ImagingRare DiseasesHepatic ArteryDoxorubicinPositron-Emission TomographyBiomedical ImagingAnimalsHumansTissue Distribution